These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1907709)

  • 21. Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?
    Eichler HG; Kong SX; Gerth WC; Mavros P; Jönsson B
    Value Health; 2004; 7(5):518-28. PubMed ID: 15367247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Forget CEA (cost effectiveness analysis). Use DEA (data envelopment analysis)!
    Rosenberg D
    J Health Hum Resour Adm; 1991; 14(1):109-12. PubMed ID: 10115636
    [No Abstract]   [Full Text] [Related]  

  • 23. Oregon's Medicaid ranking and cost-effectiveness: is there any relationship?
    Tengs TO; Meyer G; Siegel JE; Pliskin JS; Graham JD; Weinstein MC
    Med Decis Making; 1996; 16(2):99-107. PubMed ID: 8778541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cost-effectiveness of continuous subcutaneous insulin infusion compared with multiple daily injections for the management of diabetes: response to Scuffham [corrected] and Carr.
    Palmer AJ; Roze S; Valentine WJ; Spinas G
    Diabet Med; 2004 Dec; 21(12):1372; author reply 1372-3. PubMed ID: 15569145
    [No Abstract]   [Full Text] [Related]  

  • 25. Be careful in getting cost-effectiveness conclusions from a debatable trial!
    Maranzano E; Trippa F
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):314; author reply 314-5. PubMed ID: 17448887
    [No Abstract]   [Full Text] [Related]  

  • 26. An illustration of the modelling of cost and efficacy data from a clinical trial.
    Hahn S; Whitehead A
    Stat Med; 2003 Mar; 22(6):1009-24. PubMed ID: 12627415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-benefit and cost-effectiveness: methodologies for evaluating innovative pharmaceutical services.
    McGhan WF; Rowland CR; Bootman JL
    Am J Hosp Pharm; 1978 Feb; 35(2):133-40. PubMed ID: 415603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breakeven analysis.
    Jones KR
    Semin Nurse Manag; 1994 Jun; 2(2):53-4. PubMed ID: 7922655
    [No Abstract]   [Full Text] [Related]  

  • 29. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis.
    Stinnett AA; Mullahy J
    Med Decis Making; 1998; 18(2 Suppl):S68-80. PubMed ID: 9566468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous cost-effectiveness analysis and health care technology adoption.
    Jena AB; Philipson TJ
    J Health Econ; 2013 Jan; 32(1):172-80. PubMed ID: 23202262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using benefit-cost analysis to assess child abuse prevention and intervention programs.
    Plotnick RD; Deppman L
    Child Welfare; 1999; 78(3):381-407. PubMed ID: 10335597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost data for individual patients included in clinical studies: no amount of statistical analysis can compensate for inadequate costing methods.
    Graves N; Walker D; Raine R; Hutchings A; Roberts JA
    Health Econ; 2002 Dec; 11(8):735-9. PubMed ID: 12457373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Oregon priority-setting exercise: cost-effectiveness and the rule of rescue, revisited.
    Hadorn D
    Med Decis Making; 1996; 16(2):117-9. PubMed ID: 8778529
    [No Abstract]   [Full Text] [Related]  

  • 34. Health technology assessment in the cost-disutility plane.
    Eckermann S; Briggs A; Willan AR
    Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome assessment: suggestions for agency practice.
    Mordock JB
    Child Welfare; 2000; 79(6):689-710. PubMed ID: 11104154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of cardiopulmonary resuscitation training programs.
    Gorry GA; Scott DW
    Health Serv Res; 1977; 12(1):30-41. PubMed ID: 406223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies.
    Crespo C; Monleon A; Díaz W; Ríos M
    BMC Med Res Methodol; 2014 Dec; 14():139. PubMed ID: 25533141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stochastic league tables: communicating cost-effectiveness results to decision-makers.
    Hutubessy RC; Baltussen RM; Evans DB; Barendregt JJ; Murray CJ
    Health Econ; 2001 Jul; 10(5):473-7. PubMed ID: 11466807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semi-parametric regression models for cost-effectiveness analysis: improving the efficiency of estimation from censored data.
    Pullenayegum EM; Willan AR
    Stat Med; 2007 Jul; 26(17):3274-99. PubMed ID: 17309112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementary roles for toxicologic pathology and mathematics in toxicogenomics, with special reference to data interpretation and oscillatory dynamics.
    Morgan KT; Pino M; Crosby LM; Wang M; Elston TC; Jayyosi Z; Bonnefoi M; Boorman G
    Toxicol Pathol; 2004; 32 Suppl 1():13-25. PubMed ID: 15209399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.